Oct-2 forms a complex with Oct-1 on the iNOS promoter and represses transcription by interfering with recruitment of RNA PolII by Oct-1

Nucleic Acids Research

Volumn 43, Issue 20, 2015, Pages 9757-9765

  Bentrari, Fatima ^a   Chantôme, Aurelie ^a   Knights, Andrew ^b   Jeannin, Jean François ^a   Pance, Alena ^a,b  

^a UNIVERSITÉ DE BOURGOGNE   (France)

^b WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; NITRIC OXIDE SYNTHASE; ORGANIC CATION TRANSPORTER 1; ORGANIC CATION TRANSPORTER 2; RNA POLYMERASE II; DNA DIRECTED RNA POLYMERASE III; INDUCIBLE NITRIC OXIDE SYNTHASE; OCTAMER TRANSCRIPTION FACTOR 1; OCTAMER TRANSCRIPTION FACTOR 2; REPRESSOR PROTEIN;

ARTICLE; BREAST CANCER CELL LINE; COMPLEX FORMATION; CONTROLLED STUDY; ENZYME REPRESSION; EXON; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; REGULATORY MECHANISM; TRANSCRIPTION INITIATION; BREAST TUMOR; FEMALE; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; MCF-7 CELL LINE; METABOLISM; PROMOTER REGION; TUMOR CELL LINE;

BREAST NEOPLASMS; CELL LINE, TUMOR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MCF-7 CELLS; NITRIC OXIDE SYNTHASE TYPE II; OCTAMER TRANSCRIPTION FACTOR-1; OCTAMER TRANSCRIPTION FACTOR-2; PROMOTER REGIONS, GENETIC; REPRESSOR PROTEINS; RNA POLYMERASE III; TRANSCRIPTION, GENETIC;

EID: 84950151871     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkv829     Document Type: Article

References (29)

1. Phillips, K. and Luisi, B. (2000) The virtuoso of versatility: POU proteins that flex to fit. J. Mol. Biol. , 302, 1023-1039.
2. Remenyi, A. , Tomilin, A. , Scholer, H. R. and Wilmanns, M. (2002) Differential activity by DNA-induced quarternary structures of POU transcription factors. Biochem. Pharmacol. , 64, 979-984.
3. Tanaka, M. and Herr, W. (1990) Differential transcriptional activation by Oct-1 and Oct-2: interdependent activation domains induce Oct-2 phosphorylation. Cell, 60, 375-386.
4. Schild-Poulter, C. , Shih, A. , Tantin, D. , Yarymowich, N. C. , Soubeyrand, S. , Sharp, P. A. and Hache, R. J. (2007) DNA-PK phosphorylation sites on Oct-1 promote cell survival following DNA damage. Oncogene, 26, 3980-3988.
5. Shakya, A. , Kang, J. , Chumley, J. , Williams, M. A. and Tantin, D. (2011) Oct1 is a switchable, bipotential stabilizer of repressed and inducible transcriptional states. J. Biol. Chem. , 286, 450-459.
6. Theodorou, E. , Dalembert, G. , Heffelfinger, C. , White, E. , Weissman, S. , Corcoran, L. and Snyder, M. (2009) A high throughput embryonic stem cell screen identifies Oct-2 as a bifunctional regulator of neuronal differentiation. Genes Dev. , 23, 575-588.
7. Reveneau, S. , Petrakis, T. G. , Goldring, C. E. , Chantome, A. , Jeannin, J. F. and Pance, A. (2012) Oct-1 cooperates with the TATA binding initiation complex to control rapid transcription of human iNOS. Cell. Mol. Life Sci. , 69, 2609-2619.
8. Lowenstein, C. J. and Padalko, E. (2004) iNOS (NOS2) at a glance. J. Cell Sci. , 117, 2865-2867.
9. Pance, A. (2006) Nitric oxide and hormones in breast cancer: allies or enemies? Future Oncol. , 2, 275-288.
10. de Vera, M. E. , Shapiro, R. A. , Nussler, A. K. , Mudgett, J. S. , Simmons, R. L. , Morris, S. M. Jr, Billiar, T. R. and Geller, D. A. (1996) Transcriptional regulation of human inducible nitric oxide synthase (NOS2) gene by cytokines: initial analysis of the human NOS2 promoter. Proc. Natl. Acad. Sci. U. S. A. , 93, 1054-1059.
11. Carter, A. B. and Hunninghake, G. W. (2000) A constitutive active MEK -> ERK pathway negatively regulates NF-kappa B-dependent gene expression by modulating TATA-binding protein phosphorylation. J. Biol. Chem. , 275, 27858-27864.
12. Muller-Immergluck, M. M. , Schaffner, W. and Matthias, P. (1990) Transcription factor Oct-2A contains functionally redundant activating domains and works selectively from a promoter but not from a remote enhancer position in non-lymphoid (HeLa) cells. EMBO J. , 9, 1625-1634.
13. Bentrari, F. , Arnould, L. , Jackson, A. P. , Jeannin, J. F. and Pance, A. (2005) Progesterone enhances cytokine-stimulated nitric oxide synthase II expression and cell death in human breast cancer cells. Lab. Invest. , 85, 624-632.
14. Goldring, C. E. , Reveneau, S. , Chantome, A. , Pance, A. , Fleury, C. , Hume, D. A. , Sester, D. , Mignotte, B. and Jeannin, J. F. (2000) Heat shock enhances transcriptional activation of the murine-inducible nitric oxide synthase gene. FASEB J. , 14, 2393-2395.
15. Taylor, B. S. , de Vera, M. E. , Ganster, R. W. , Wang, Q. , Shapiro, R. A. , Morris, S. M. Jr, Billiar, T. R. and Geller, D. A. (1998) Multiple NF-kappaB enhancer elements regulate cytokine induction of the human inducible nitric oxide synthase gene. J. Biol. Chem. , 273, 15148-15156.
16. Kristof, A. S. , Marks-Konczalik, J. and Moss, J. (2001) Mitogen-activated protein kinases mediate activator protein-1-dependent human inducible nitric-oxide synthase promoter activation. J. Biol. Chem. , 276, 8445-8452.
17. Zhu, X. , Wu, L. , Zhang, L. , Hao, P. , Zhang, S. , Huang, J. , Zheng, J. , Liu, Y. , Li, W. , Zhang, Y. et al. (2010) Distinct regulatory mechanism of immunoglobulin gene transcription in epithelial cancer cells. Cell. Mol. Immunol. , 7, 279-286.
18. Azuara-Liceaga, E. , Sandoval, M. , Corona, M. , Gariglio, P. and Lopez-Bayghen, E. (2004) The human involucrin gene is transcriptionally repressed through a tissue-specific silencer element recognized by Oct-2. Biochem. Biophys. Res. Commun. , 318, 361-371.
19. Du, Q. , Zhang, X. , Cardinal, J. , Cao, Z. , Guo, Z. , Shao, L. and Geller, D. A. (2009) Wnt/beta-catenin signaling regulates cytokine-induced human inducible nitric oxide synthase expression by inhibiting nuclear factor-kappaB activation in cancer cells. Cancer Res. , 69, 3764-3771.
20. Gochman, E. , Mahajna, J. , Shenzer, P. , Dahan, A. , Blatt, A. , Elyakim, R. and Reznick, A. Z. (2012) The expression of iNOS and nitrotyrosine in colitis and colon cancer in humans. Acta Histochem. , 114, 827-835.
21. Remenyi, A. , Scholer, H. R. and Wilmanns, M. (2004) Combinatorial control of gene expression. Nat. Struct. Mol. Biol. , 11, 812-815.
22. Remenyi, A. , Tomilin, A. , Pohl, E. , Lins, K. , Philippsen, A. , Reinbold, R. , Scholer, H. R. and Wilmanns, M. (2001) Differential dimer activities of the transcription factor Oct-1 by DNA-induced interface swapping. Mol. Cell, 8, 569-580.
23. Donner, A. L. , Episkopou, V. and Maas, R. L. (2007) Sox2 and Pou2f1 interact to control lens and olfactory placode development. Dev. Biol. , 303, 784-799.
24. Rhee, J. M. , Trieu, M. and Turner, E. E. (2001) Optimal Oct-2 affinity for an extended DNA site and the effect of GST fusion on site preference. Arch. Biochem. Biophys. , 385, 397-405.
25. Verrijzer, C. P. , van Oosterhout, J. A. and van der Vliet, P. C. (1992) The Oct-1 POU domain mediates interactions between Oct-1 and other POU proteins. Mol. Cell. Biol. , 12, 542-551.
26. Cleary, M. A. , Stern, S. , Tanaka, M. and Herr, W. (1993) Differential positive control by Oct-1 and Oct-2: activation of a transcriptionally silent motif through Oct-1 and VP16 corecruitment. Genes Dev. , 7, 72-83.
27. Sturm, R. A. , Das, G. and Herr, W. (1988) The ubiquitous octamer-binding protein Oct-1 contains a POU domain with a homeo box subdomain. Genes Dev. , 2, 1582-1599.
28. Sharif, M. N. , Radomska, H. S. , Miller, D. M. and Eckhardt, L. A. (2001) Unique function for carboxyl-terminal domain of Oct-2 in Ig-secreting cells. J. Immunol. , 167, 4421-4429.
29. Kang, J. , Shen, Z. , Lim, J. M. , Handa, H. , Wells, L. and Tantin, D. (2013) Regulation of Oct1/Pou2f1 transcription activity by O-GlcNAcylation. FASEB J. , 27, 2807-2817.